Presentations and Articles

Note: Some of the documents linked to this page are in Portable Document Format (PDF), and require the Adobe® Acrobat Reader for viewing. If you do not have the Acrobat Reader, visit https://get.adobe.com/reader/ to download.

NIH Technology Transfer Training This training is mandatory for the following groups at NIH: (NOTE: This link will only work from within NIH firewall) All Principal Investigators (Senior Investigators, Investigators, Adjunct Investigators, Senior Scientists/Clinicians, and Assistant Clinical Investigators ) Fellows Graduate Students Staff Scientists/Staff Clinicians

Licensing to Improve Global Access to Medicines During Public health Emergencies and Beyond Ami Gadhia, Steven Ferguson, Mark Rohrbaugh LES Viewpoints Vol. XXXI No. 1 2023 May; 1-3
Role of Global Public Sector Research in Discovering New Drugs and Vaccines Ashley J. Stevens, David E. Benson, Sara E. Dodson, Jonathan J. Jensen, Mark L. Rohrbaugh The Journal of Technology Transfer (2023)
An Early TTO for U.S. Federal Labs - The National Technical Information Service Steven Ferguson Les Nouvelles Vol LVIII no 1. 2023 Mar; 93-95
NCATS Breaks the Mold: Case Studies of Unique Tech Transfer Mechanisms Ami D. Gadhia, Rebecca A. Erwin-Cohen, Krishna (Balki) Balakrishnan, Lili M. Portilla Technology Transfer Tactics. 2022 Sep; 154-158
Hiding in Plain Sight: Surprising Pharma and Biotech Connections to NIH's National Cancer Institute Berna Uygur, Steven Ferguson, and Michael Pollack J Commer Biotechnol. 2022 Jul 17; 27(2): 5–13.
Considerations for Potential Global Expansion of Serum Institute of India Veena Somasundaram, Peter Soukas, Jenish Patel, and Steven Ferguson 2021 Dec; 26(4): 10.5912/jcb1006
Guide to Federal Technology Transfer in Maryland Maryland Department of Economic Development 2021 Jul
OSA/NCATS Workshop: Expectations and Impact of TT
OSA/NCATS Workshop: Innovation In and Measuring TT
The U.S. National Institutes of Health – Founding A National Biomedical “Innovation Ecosystem” Steven M. Ferguson and Lynn Johnson Langer J Commer Biotechnol. 2021 Mar; 26(1): 72–82.
Licensing the Technology: Biotechnology Commercialization Strategies Using University and Federal Labs (2nd Edition) Steven M. Ferguson and Uma S. Kaundinya In: Craig Shimasaki, ed. Biotechnology Entrepreneurship: Starting, Managing, and Leading Biotech Companies. (Elsevier Inc.) 2020:199-222.
I-Corps at NIH: Entrepreneurial Training Program Creating Successful Small Businesses Christie A Canaria, Lili Portilla, Michael Weingarten Clin Transl Sci. 2019 Jul;12(4):324-328
Intellectual Property and Technology Transfer Bruce Goldstein In: JI Gallin, FP Ognibene, LL Johnson, eds. Principles and Practice of Clinical Research (Fourth Edition). (Academic Press/Elsevier Inc.) 2017:447–529.
A Guide to Time Lag and Time Lag Shortening Strategies in Oncology-Based Drug Development Berna Uygur, Josh Duberman, and Steven M. Ferguson J Commer Biotechnol. 2017 May;23(2):75-81.
Beyond Hybrid Licenses—Strategies for Post Patent Expiration Payments in the United States Patrick Gattari, Steven Ferguson, David Crichton, and Bryan Helwig les Nouvelles. 2017 Mar;52(1):31-6.
How SBIR and STTR Can Support Women in Biotech Funding for Innovation from NIH’s Small Business Programs   Interview with Lili Portilla In: Association for Women in Science, 2017;49:36-27
The Commercialization of New Drugs and Vaccines Discovered in Public Sector Research Stevens, A.J., Jensen, J.J., Wyller, K., Kilgore, P.C., London, E., Zhang, Q., Chatterjee, S., and Rohrbaugh, M.L, In: S.M. Breznitz and H. Etzkowitz, eds., Routledge, University Technology Transfer: The Globalization of Academic Innovation, 2016:102-145
NIH Inventions Translate into Drugs and Biologics with High Public Health Impact  Sabarni K. Chatterjee and Mark L. Rohrbaugh Nat Biotechnol. 2014 Jan 9;32(1):52-58.
Collaborative Development of 2-hydroxypropyl-β-cyclodextrin for the Treatment of Niemann-Pick Type C1 Disease  Lili Portilla  Curr Top Med Chem. 2014;14(3):330-339
Leveraging Public Private Partnerships to Innovate Under Challenging Budget Times  Lili Portilla and Mark L. Rohrbaugh  Curr Top Med Chem. 2014;14(3):326-329
If The Sky Were The Limit, What Would You Do In Technology Transfer? Gary Keller, Fizie Haleem, Steven Ferguson, Al Jordan, and Cheryl Cejka les Nouvelles. 2013 Mar;47(1):66-70.
Leveraging Public Private Partnerships to Innovate Under Challenging Budget Times  Portilla, L.M. and Rohrbaugh, M.L.  Current Topics in Med. Chem., 2014;14(3):326-329
Intellectual Property Claims to Stem Cell Technologies: Research Clinical Testing and Product Sales Hammersla, A.M. and Rohrbaugh, M.L., In: Progenitor and Stem Cell Technologies and Therapies, A. Atala, ed., Woodhead Publishing Ltd. 2012
Stem Cell Patents: What Every Researcher Should Know Mark L. Rohrbaugh In: Human Stem Cell Manual: A Laboratory Guide, JF Loring, SE Peterson, eds., Elsevier Press 2012;2
Partnering with the NIH: Now part of the "Value Proposition" for start-ups Steven M. Ferguson J Commer Biotechnol. 2012 Apr 1;18(2):60-67.
License Compliance Issues for Biopharmaceuticals: Special Challenges for Negotiations between Companies and Non-Profit Research Institutions Todd A. Ponzio, Hans Feindt, and Steven M. Ferguson les Nouvelles, 2011 Sep;46(3):216-25.
The Role of Public-Sector Research in the Discovery of Drugs and Vaccines Ashley J. Stevens, Jonathan J. Jensen, Katrine Wyller, Patrick C. Kilgore, Sabarni Chatterjee, and Mark L. Rohrbaugh N Engl J Med. 2011 Feb 10;364(6):535-41.

Presentations & Articles Archive